107 related articles for article (PubMed ID: 8605163)
1. Complexation of the tissue plasminogen activator protease with benzamidine-type inhibitors: interference by the kringle 2 module.
Hu CK; Kohnert U; Sturzebecher J; Fischer S; Llinas M
Biochemistry; 1996 Mar; 35(10):3270-6. PubMed ID: 8605163
[TBL] [Abstract][Full Text] [Related]
2. Tissue-type plasminogen activator domain-deletion mutant BM 06.022: modular stability, inhibitor binding, and activation cleavage.
Hu CK; Kohnert U; Wilhelm O; Fischer S; Llinás M
Biochemistry; 1994 Oct; 33(39):11760-6. PubMed ID: 7918392
[TBL] [Abstract][Full Text] [Related]
3. Mapping of the catalytic site of CHO-t-PA and the t-PA variant BM 06.022 by synthetic inhibitors and substrates.
Stürzebecher J; Neumann U; Kohnert U; Kresse GB; Fischer S
Protein Sci; 1992 Aug; 1(8):1007-13. PubMed ID: 1304379
[TBL] [Abstract][Full Text] [Related]
4. The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain.
Rydzewski A; Castellino FJ
Arch Biochem Biophys; 1993 Jan; 300(1):472-82. PubMed ID: 8424682
[TBL] [Abstract][Full Text] [Related]
5. Recombinant gene expression and 1H NMR characteristics of the kringle (2 + 3) supermodule: spectroscopic/functional individuality of plasminogen kringle domains.
Söhndel S; Hu CK; Marti D; Affolter M; Schaller J; Llinás M; Rickli EE
Biochemistry; 1996 Feb; 35(7):2357-64. PubMed ID: 8652577
[TBL] [Abstract][Full Text] [Related]
6. Lysine 156 promotes the anomalous proenzyme activity of tPA: X-ray crystal structure of single-chain human tPA.
Renatus M; Engh RA; Stubbs MT; Huber R; Fischer S; Kohnert U; Bode W
EMBO J; 1997 Aug; 16(16):4797-805. PubMed ID: 9305622
[TBL] [Abstract][Full Text] [Related]
7. Nuclear magnetic resonance (NMR) solution structure, dynamics, and binding properties of the kringle IV type 8 module of apolipoprotein(a).
Chitayat S; Kanelis V; Koschinsky ML; Smith SP
Biochemistry; 2007 Feb; 46(7):1732-42. PubMed ID: 17263558
[TBL] [Abstract][Full Text] [Related]
8. Role of tryptophan-63 of the kringle 2 domain of tissue-type plasminogen activator in its thermal stability, folding, and ligand binding properties.
Chang Y; Zajicek J; Castellino FJ
Biochemistry; 1997 Jun; 36(25):7652-63. PubMed ID: 9201906
[TBL] [Abstract][Full Text] [Related]
9. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ
J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954
[TBL] [Abstract][Full Text] [Related]
10. Ligand preferences of kringle 2 and homologous domains of human plasminogen: canvassing weak, intermediate, and high-affinity binding sites by 1H-NMR.
Marti DN; Hu CK; An SS; von Haller P; Schaller J; Llinás M
Biochemistry; 1997 Sep; 36(39):11591-604. PubMed ID: 9305949
[TBL] [Abstract][Full Text] [Related]
11. Active site labeling with dansyl-glutamyl-glycyl-arginyl chloromethyl ketone demonstrates the full activity of the refolded and purified tissue-type plasminogen activator variant BM 06.022.
Kohnert U; Wozny M; Llinas M; Roos A; Fischer S
Appl Biochem Biotechnol; 1995 Nov; 55(2):157-66. PubMed ID: 7495332
[TBL] [Abstract][Full Text] [Related]
12. Spatial orientation of tissue-type plasminogen activator bound at the melanoma cell surface.
Bizik J; Trancikova D; Felnerova D; Verheijen JH; Vaheri A
Biochem Biophys Res Commun; 1997 Oct; 239(1):322-8. PubMed ID: 9345318
[TBL] [Abstract][Full Text] [Related]
13. A kringle-containing protease with plasminogen-like activity in the basal chordate Branchiostoma belcheri.
Liu M; Zhang S
Biosci Rep; 2009 Sep; 29(6):385-95. PubMed ID: 19193194
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and expression of a gene from kringle-2 domain of tissue plasminogen activator in E. coli.
Hua ZC; Fu HL; Chen YH; Yu RR; Wang J; Zhu DX
Sci China B; 1994 Jun; 37(6):667-76. PubMed ID: 7917003
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein(a): structure-function relationship at the lysine-binding site and plasminogen activator cleavage site.
Anglés-Cano E; Rojas G
Biol Chem; 2002 Jan; 383(1):93-9. PubMed ID: 11928826
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional analyses of benzamidine-based inhibitors in complex with trypsin: implications for the inhibition of factor Xa, tPA, and urokinase.
Renatus M; Bode W; Huber R; Stürzebecher J; Stubbs MT
J Med Chem; 1998 Dec; 41(27):5445-56. PubMed ID: 9876114
[TBL] [Abstract][Full Text] [Related]
17. The 2.3 A crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator.
Lamba D; Bauer M; Huber R; Fischer S; Rudolph R; Kohnert U; Bode W
J Mol Biol; 1996 Apr; 258(1):117-35. PubMed ID: 8613982
[TBL] [Abstract][Full Text] [Related]
18. 1H NMR structural characterization of a recombinant kringle 2 domain from human tissue-type plasminogen activator.
Byeon IJ; Kelley RF; Llinás M
Biochemistry; 1989 Nov; 28(24):9350-60. PubMed ID: 2558718
[TBL] [Abstract][Full Text] [Related]
19. 19F NMR studies of plasminogen activator inhibitor-1.
Abbott GL; Blouse GE; Perron MJ; Shore JD; Luck LA; Szabo AG
Biochemistry; 2004 Feb; 43(6):1507-19. PubMed ID: 14769027
[TBL] [Abstract][Full Text] [Related]
20. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
